Literature DB >> 32401054

Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies: Guideline From the College of American Pathologists in Collaboration With the American College of Chest Physicians, Association for Molecular Pathology, American Society of Cytopathology, American Thoracic Society, Pulmonary Pathology Society, Papanicolaou Society of Cytopathology, Society of Interventional Radiology, and Society of Thoracic Radiology.

Sinchita Roy-Chowdhuri1, Sanja Dacic1, Mohiedean Ghofrani1, Peter B Illei1, Lester J Layfield1, Christopher Lee1, Claire W Michael1, Ross A Miller1, Jason W Mitchell1, Boris Nikolic1, Jan A Nowak1, Nicholas J Pastis1, Carol Ann Rauch1, Amita Sharma1, Lesley Souter1, Brooke L Billman1, Nicole E Thomas1, Paul A VanderLaan1, Jesse S Voss1, Momen M Wahidi1, Lonny B Yarmus1, Christopher R Gilbert1.   

Abstract

CONTEXT.—: The need for appropriate specimen use for ancillary testing has become more commonplace in the practice of pathology. This, coupled with improvements in technology, often provides less invasive methods of testing, but presents new challenges to appropriate specimen collection and handling of these small specimens, including thoracic small biopsy and cytology samples. OBJECTIVE.—: To develop a clinical practice guideline including recommendations on how to obtain, handle, and process thoracic small biopsy and cytology tissue specimens for diagnostic testing and ancillary studies. METHODS.—: The College of American Pathologists convened an expert panel to perform a systematic review of the literature and develop recommendations. Core needle biopsy, touch preparation, fine-needle aspiration, and effusion specimens with thoracic diseases including malignancy, granulomatous process/sarcoidosis, and infection (eg, tuberculosis) were deemed within scope. Ancillary studies included immunohistochemistry and immunocytochemistry, fluorescence in situ hybridization, mutational analysis, flow cytometry, cytogenetics, and microbiologic studies routinely performed in the clinical pathology laboratory. The use of rapid on-site evaluation was also covered. RESULTS.—: Sixteen guideline statements were developed to assist clinicians and pathologists in collecting and processing thoracic small biopsy and cytology tissue samples. CONCLUSIONS.—: Based on the systematic review and expert panel consensus, thoracic small specimens can be handled and processed to perform downstream testing (eg, molecular markers, immunohistochemical biomarkers), core needle and fine-needle techniques can provide appropriate cytologic and histologic specimens for ancillary studies, and rapid on-site cytologic evaluation remains helpful in appropriate triage, handling, and processing of specimens.

Entities:  

Year:  2020        PMID: 32401054     DOI: 10.5858/arpa.2020-0119-CP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

Review 1.  Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer.

Authors:  Pasquale Pisapia; Francesco Pepe; Antonino Iaccarino; Roberta Sgariglia; Mariantonia Nacchio; Floriana Conticelli; Maria Salatiello; Rossella Tufano; Gianluca Russo; Gianluca Gragnano; Ilaria Girolami; Albino Eccher; Umberto Malapelle; Giancarlo Troncone
Journal:  Front Med (Lausanne)       Date:  2021-02-11

2.  Adequacy of pleural fluid cytology for comprehensive molecular analysis of lung adenocarcinoma: Experience of a large health-care system.

Authors:  Siddhartha Dilip Dalvi; Karen Chau; Sujata Sajjan; Baidarbhi Chakraborty; Priyanka Karam; Seema Khutti; Cecilia Gimenez; Kasturi Das
Journal:  Cytojournal       Date:  2022-02-04       Impact factor: 2.091

3.  Evaluation of Cytologic Sample Preparations for Compatibility With Nucleic Acid Analysis.

Authors:  Laure Sorber; Bart Claes; Karen Zwaenepoel; Bieke Van Dorst; Koen De Winne; Els Fransen; Reinier Wener; Therese Lapperre; Filip Lardon; Patrick Pauwels
Journal:  Am J Clin Pathol       Date:  2022-02-03       Impact factor: 2.493

4.  Navigational bronchoscopy specimens and PD-L1 expression: a retrospective study.

Authors:  Hussein Asad; Timothy Saettele; Ossama Tawfik; Philip Jones; Matthew Aboudara
Journal:  J Thorac Dis       Date:  2022-02       Impact factor: 2.895

Review 5.  Expert opinion on NSCLC small specimen biomarker testing - Part 1: Tissue collection and management.

Authors:  Frédérique Penault-Llorca; Keith M Kerr; Pilar Garrido; Erik Thunnissen; Elisabeth Dequeker; Nicola Normanno; Simon J Patton; Jenni Fairley; Joshua Kapp; Daniëlle de Ridder; Aleš Ryška; Holger Moch
Journal:  Virchows Arch       Date:  2022-07-20       Impact factor: 4.535

Review 6.  INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists' View.

Authors:  Zahra Maleki; Akash Nadella; Mohnish Nadella; Gopi Patel; Shivni Patel; Ivana Kholová
Journal:  Diagnostics (Basel)       Date:  2021-11-23

Review 7.  PD-L1 and beyond: Immuno-oncology in cytopathology.

Authors:  Antonino Iaccarino; Maria Salatiello; Ilaria Migliatico; Caterina De Luca; Gianluca Gragnano; Maria Russo; Claudio Bellevicine; Umberto Malapelle; Giancarlo Troncone; Elena Vigliar
Journal:  Cytopathology       Date:  2021-05-06       Impact factor: 2.073

Review 8.  Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing.

Authors:  Esther Conde; Federico Rojo; Javier Gómez; Ana Belén Enguita; Ihab Abdulkader; Ana González; Dolores Lozano; Nuria Mancheño; Clara Salas; Marta Salido; Eduardo Salido-Ruiz; Enrique de Álava
Journal:  J Clin Pathol       Date:  2021-04-19       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.